Currencies / BEAM
BEAM: Beam Therapeutics Inc
16.36
USD
0.49
(2.91%)
BEAM exchange rate has changed by -2.91% for today. During the day, the instrument was traded at a low of 16.26 and at a high of 17.01.
Follow Beam Therapeutics Inc dynamics. Real-time quotes will help you quickly react to market changes. By switching between different timeframes, you can monitor exchange rate trends and dynamics by minutes, hours, days, weeks, and months. Use this information to forecast market changes and to make informed trading decisions.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BEAM News
- Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?
- CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?
- CRISPR Therapeutics Gains 41.4% in 3 Months: How to Play the Stock
- Cathie Wood’s ARK buys Robinhood, CRISPR, sells Genius Sports stock
- Cantor Fitzgerald reiterates Overweight rating on Beam Therapeutics stock
- Cathie Wood’s ARK ETF bolsters biotech, trims defense stock
- Beam Therapeutics: A Slow-Developing Story (NASDAQ:BEAM)
- Pfizer's Investigational Drug Flunks Late-Stage For Sickle Cell Disease - Pfizer (NYSE:PFE)
- Beam Therapeutics stock surges after FDA grants RMAT designation
- FDA grants RMAT designation to Beam Therapeutics’ sickle cell therapy
- Can Rising Casgevy Sales Aid CRISPR Therapeutics Post Q2 Earnings?
- Tracking Cathie Wood’s ARK Invest 13F Portfolio – Q2 2025 Update (BATS:ARKK)
- BEAM's Q2 Loss Narrower Than Expected, Revenues Miss Mark
- Clear Street reiterates Buy rating on Beam Therapeutics stock at $34
- Beam earnings beat by $0.11, revenue fell short of estimates
- Beam Therapeutics Inc. (BEAM) Reports Q2 Loss, Misses Revenue Estimates
- Vir Biotechnology, Inc. (VIR) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
- 3 Genomics Stocks Worth Adding to Your Portfolio in 2025
- Will Beam Therapeutics Inc. (BEAM) Report Negative Q2 Earnings? What You Should Know
- Cathie Wood’s ARK buys Tempus AI stock, sells Block and Roku
- Cathie Wood’s ARK buys CRSP stock, sells ROKU and MASS
- Cathie Wood shells out $13.9 million for one high-stakes biotech stock
- Cathie Wood’s ARK ETF bolsters Beam stock, sheds Roblox
- Cathie Wood’s ARK adjusts with Beam, Compass, and Komatsu trades
Daily Range
16.26
17.01
Year Range
13.52
35.25
- Previous Close
- 16.85
- Open
- 16.87
- Bid
- 16.36
- Ask
- 16.66
- Low
- 16.26
- High
- 17.01
- Volume
- 3.486 K
- Daily Change
- -2.91%
- Month Change
- -14.21%
- 6 Months Change
- -38.36%
- Year Change
- -37.77%
30 August, Saturday